Growth Metrics

Sarepta Therapeutics (SRPT) Amortization - Intangibles (2016 - 2025)

Historic Amortization - Intangibles for Sarepta Therapeutics (SRPT) over the last 9 years, with Q2 2025 value amounting to $667000.0.

  • Sarepta Therapeutics' Amortization - Intangibles rose 1098.17% to $667000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $2.5 million, marking a year-over-year increase of 278.7%. This contributed to the annual value of $2.4 million for FY2024, which is 5426.56% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Amortization - Intangibles stood at $667000.0 for Q2 2025, which was up 1098.17% from $601000.0 recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' Amortization - Intangibles registered a high of $763000.0 during Q4 2023, and its lowest value of $170000.0 during Q1 2021.
  • Over the past 5 years, Sarepta Therapeutics' median Amortization - Intangibles value was $179000.0 (recorded in 2021), while the average stood at $355941.2.
  • As far as peak fluctuations go, Sarepta Therapeutics' Amortization - Intangibles surged by 32625.7% in 2023, and later plummeted by 2123.2% in 2024.
  • Sarepta Therapeutics' Amortization - Intangibles (Quarter) stood at $179000.0 in 2021, then changed by 0.0% to $179000.0 in 2022, then skyrocketed by 326.26% to $763000.0 in 2023, then fell by 21.23% to $601000.0 in 2024, then rose by 10.98% to $667000.0 in 2025.
  • Its Amortization - Intangibles stands at $667000.0 for Q2 2025, versus $601000.0 for Q4 2024 and $602000.0 for Q3 2024.